In NB, resistance to TRAIL-induced apoptosis has been preferentially described in MYCN-amplified tumours and correlates with inactivation of caspase 8 gene secondary to gene deletion or silencing through DNA hypermethylation (Hopkins-Donaldson et al, 2000; Teitz et al, 2000). The gene discussed is MYCN; the disease is neuroblastoma.